Position in ACHV
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$530,098
+$475,265 QoQ
Shares Held
81,179
+335.3% QoQ
Ownership
0.079%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#44
of 111 holders
Holding Since
Jun 2022
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ACHV Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Diametric Capital, LP holds $91,993,189 across 32 Biotechnology names. ACHV ranks #17 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PGEN |
Precigen, Inc.
|
9,269,926 | $52,838,578 | |
| 2 | QURE |
uniQure N.V.
|
197,242 | $9,084,966 | |
| 3 | ABVX |
Abivax S.A.
|
51,903 | $6,916,593 | |
| 4 | ABEO |
Abeona Therapeutics Inc.
|
755,021 | $4,666,029 | |
| 5 | ZVRA |
Zevra Therapeutics, Inc.
|
231,465 | $3,319,208 | |
| 6 | UNCY |
Unicycive Therapeutics, Inc.
|
374,132 | $1,754,679 | |
| 7 | ANAB |
Anaptysbio, Inc
|
16,868 | $1,138,590 | |
| 8 | NKTR |
Nektar Therapeutics
|
15,967 | $1,114,656 |
All Filings in ACHV
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $530,098 | 81,179 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $54,833 | 18,651 | Shares | Defined | 2026-05-15 | |
| 2023-12-31 | $77,262 | 18,753 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $340,603 | 79,210 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $436,364 | 84,078 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $315,513 | 46,399 | Shares | Defined | 2023-05-11 | |
| 2022-12-31 | $48,762 | 19,903 | Shares | Defined | 2023-03-29 | |
| 2022-09-30 | $114,378 | 34,660 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $95,194 | 19,507 | Shares | Defined | 2022-08-15 | |
| No filing history on record for this holder in this stock. | ||||||